Bay Area/ San Francisco/ Science, Tech & Medicine

Gilead Opens 182,000-Square-Foot Cancer Research Hub in Foster City

AI Assisted Icon
Published on November 19, 2026
Gilead Opens 182,000-Square-Foot Cancer Research Hub in Foster CitySource: Suiren2022 / Wikimedia Commons

Gilead Sciences has opened a 182,000-square-foot Research Center at its Foster City headquarters, a five-story laboratory building designed to house roughly 325 employees, including 260 laboratory scientists, as the company pushes to speed up its next generation of medicines. The center brings together Gilead's oncology, inflammation and research data science teams under one roof, a structural choice the company says is meant to accelerate drug discovery.

Gilead celebrated the opening on September 8, according to a Gilead Sciences announcement syndicated by Yahoo Finance. More than two months later, general contractor Suffolk marked its own role in the project, announcing that it had completed the building and joined Gilead to celebrate the milestone, per a Suffolk announcement syndicated by Yahoo Finance. Suffolk said it also provided commissioning, qualification and validation services to help transition the facility into an operational research environment.

Labs Built to Change Shape Without a Wrecking Ball

Inside, the building features suites of laboratories on each floor, with dedicated spaces set aside for specialized research equipment and the handling of biological materials, the same Suffolk release notes. The design leans heavily on flexibility: movable interior panels, along with extra power, data and lab-gas connections, are meant to let laboratories and other spaces be reconfigured without demolition, according to a Suffolk announcement syndicated by FinancialContent. That setup is intended to let the space evolve alongside Gilead's research needs as teams, equipment and technologies shift over time, per Construction Review.

Gilead has described the facility as equipped with autonomous robots, augmented reality tools and digital twin technology, framing it as a showcase for how research work gets done going forward. Gilead Sciences said in its own materials that “everything from autonomous robots to augmented reality and digital twins will be part of the center.” The Tradeline trade publication, citing architecture firm Gensler's design brief, reported that the 182,000-square-foot facility was built to catalyze synergies between 54 clinical programs spanning oncology, inflammation and virology, according to Tradeline.

Part of a Bigger Foster City Buildout

Gilead has framed the Research Center as one of three major Foster City campus projects tied to its broader U.S. investment in research, development and manufacturing through 2030, according to Gilead Sciences. The company has said the opening marks the latest milestone in a $32 billion U.S. investment plan running through the end of the decade, and in separate materials projected that its direct capital and jobs creation would generate approximately $43 billion in value for the U.S. economy over five years, per Gilead Sciences. Gilead's Technical Development Center is expected to open in 2027, and a biologics facility that broke ground in August is expected to open in 2029, the company said.

Gilead also said the center's all-electric systems, energy-efficient design and water-saving landscaping are expected to support LEED Gold certification.

Suffolk's Playbook, From Foster City to Providence

During construction, Suffolk used OpenSpace for visual documentation and progress tracking while evaluating tools from Dusty Robotics, Kaya.ai and ALICE Technologies, with the builder saying the combination improved project visibility and helped reduce the potential for rework. Construction Review reported that Dusty Robotics supported construction precision, ALICE Technologies supported sequencing, and OpenSpace supported coordination throughout the build.

Suffolk says the Foster City project adds to a nationwide life sciences portfolio that now tops 14 million square feet, including Takeda's Global Research and Development Center in Cambridge, Massachusetts, and the expansion of Regeneron Pharmaceuticals' headquarters in Tarrytown, New York, according to the FinancialContent-syndicated release. The builder is also currently delivering Brown University's 300,000-square-foot Integrated Life Sciences Building in Providence, Rhode Island, the same announcement states.